hyperkalemia in hemodialysis patients. Chronic kidney disease, stage 5
Conditions
Interventions
Intervention 1: Intervention group: Dialysis with 2 meq/l potassium dialysate to which 17.5 cc ampoules of 15% potassium chloride have been added per liter of concentrated dialysis solution (equivalen
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 75 Years
Inclusion criteria
Inclusion criteria: hemodialysis for more than 3 months stable physical and labaratory condition regular treatment program (3 times dialysis per week) stable vascular access stable blood pressure stable hemodynamic and cardiovascular condition serum potassium less than or equal to 4.5 The patient should be hospitalized. (for the convenience of measuring potassium 6 hours after the end of dialysis)
Exclusion criteria
Exclusion criteria: need a blood transfusion for any reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum potassium level. Timepoint: Measurement of serum potassium in patients before dialysis, immediately after dialysis, 6 hours after dialysis. Method of measurement: Serum potassium measurement of patients in the laboratory by electrode method and using EasyLyte REF 2124 device.;Dialysate potassium level. Timepoint: Measurement of potassium level of dialysate during dialysis from afferent and efferent coupling. Method of measurement: dialysate potassium measurement in the laboratory by electrode method and using EasyLyte REF 2124 device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehran Haddadi
Esfahan University of Medical Sciences
Outcome results
None listed